PMBPX
Price
$44.27
Change
-$0.76 (-1.69%)
Updated
Feb 21 closing price
Net Assets
30.08B
WMGYX
Price
$27.16
Change
-$0.73 (-2.62%)
Updated
Feb 21 closing price
Net Assets
5.84B
Ad is loading...

PMBPX vs WMGYX

Header iconPMBPX vs WMGYX Comparison
Open Charts PMBPX vs WMGYXBanner chart's image
Principal MidCap R5
Price$44.27
Change-$0.76 (-1.69%)
VolumeN/A
Net Assets30.08B
Macquarie Mid Cap Growth Y
Price$27.16
Change-$0.73 (-2.62%)
VolumeN/A
Net Assets5.84B
PMBPX vs WMGYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMBPX vs. WMGYX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBPX is a StrongBuy and WMGYX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 30.1B vs. WMGYX (5.84B). PMBPX (0.00) and WMGYX (0.00) have matching dividends . PMBPX was incepted earlier than WMGYX: PMBPX (24 years) vs WMGYX (25 years). WMGYX is a more actively managed with annual turnover of: 23.00 vs. PMBPX (10.10). PMBPX (0) and WMGYX (0) have matching initial minimum investment requirements. PMBPX annual gain was more profitable for investors over the last year : 17.07 vs. WMGYX (-2.42). PMBPX return over 5 years is better than : 38.64 vs. WMGYX (-6.96).
PMBPXWMGYXPMBPX / WMGYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years25 years-
Gain YTD4.5333.600126%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets30.1B5.84B515%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.07-2.42-705%
Returns for 3 years29.51-15.06-196%
Returns for 5 years38.64-6.96-555%
Returns for 10 years97.5116.72583%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY17.330.44
+2.61%
Bally's Corporation
BIO285.631.90
+0.67%
Bio-Rad Laboratories IncClass A
GPUS3.150.02
+0.64%
Hyperscale Data Inc
PTGX38.49-0.04
-0.10%
Protagonist Therapeutics
MIST2.06-0.07
-3.29%
Milestone Pharmaceuticals